HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Internationl PLC
Previous close
$21.80
Day range
$21.29 - $22.28
Year range
$15.52 - $28.15
Market cap
1.55B USD
Avg Volume
321.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 112.21M | 67.37% |
Operating expense | 72.46M | 40.49% |
Net income | -12.69M | 8.39% |
Net profit margin | -11.31 | 45.26% |
Earnings per share | -0.18 | 10.00% |
EBITDA | -9.26M | 10.32% |
Effective tax rate | -76.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 223.78M | 11.29% |
Total assets | 555.30M | 14.95% |
Total liabilities | 118.29M | 51.78% |
Total equity | 437.01M | — |
Shares outstanding | 72.20M | — |
Price to book | 3.60 | — |
Return on assets | -4.40% | — |
Return on capital | -5.40% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.69M | 8.39% |
Cash from operations | -2.24M | -113.16% |
Cash from investing | -6.35M | 48.29% |
Cash from financing | 6.69M | 1,111.78% |
Net change in cash | -1.90M | -136.02% |
Free cash flow | 8.65M | -30.75% |
About
Founded
2015
Website
Employees
297
